サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：分子輸送培地の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 製品タイプ別、用途別、サンプル別、エンドユーザー別、地域別
市場調査レポート
商品コード
1397264

分子輸送培地の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 製品タイプ別、用途別、サンプル別、エンドユーザー別、地域別

Molecular Transport Medium Market - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America & Middle East & Africa)
出版日: | 発行: Fairfield Market Research | ページ情報: 英文 336 Pages | 納期: 2～5営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
分子輸送培地の世界市場 - 世界の業界分析、規模、シェア、成長、動向、予測（2031年）- 製品タイプ別、用途別、サンプル別、エンドユーザー別、地域別
出版日: 2023年12月06日
発行: Fairfield Market Research
ページ情報: 英文 336 Pages
納期: 2～5営業日
  • 全表示
  • 概要
  • 目次
概要

世界の分子輸送培地の市場規模は、2021年に16億米ドルの売上となり、一時的な落ち込みを経験しましたが、現在は着実な成長を遂げています。予測では、市場は2031年までに12億米ドルに達すると予測されています。

技術の進歩により、従来の輸送媒体から革新的な分子輸送培地への移行が進み、安全性と利便性が向上しています。これらの新製品は、輸送、保管、処理において、非危険物で漏れのない処方により暴露リスクを低減します。

サンプル採取後の劣化や細胞死を防ぐためには迅速な保存が不可欠であるため、輸送・保存中のサンプルの安定性を保つことも重要な推進力となっています。分子輸送培地は、保存・輸送中のサンプルの安定性を約48時間維持し、凍結融解の必要性を回避する上で重要な役割を果たします。

検体を安定化させるための代替ソリューション、特にウイルス、細菌、真菌の検出は、分子輸送培地市場にとって課題となります。これらの溶液は、中性pHを維持するために生理食塩水や緩衝塩溶液を使用することが多いです。研究者たちは、ウイルスの安定性を高めるために、植物ベースのタンパク質サプリメントを模索しています。

当レポートでは、世界の分子輸送培地市場について調査し、市場の概要とともに、製品タイプ別、用途別、サンプル別、エンドユーザー別、地域別動向、および市場に参入する企業の競合動向などを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の定義とセグメンテーション
  • 市場力学
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • COVID-19の影響分析
  • ウクライナとロシアの紛争の影響
  • 経済概要
  • PESTLE分析

第3章 世界の分子輸送培地市場の見通し、2018年～2031年

  • 世界の分子輸送培地市場の見通し、製品タイプ別、金額（10億米ドル）、2018年～2031年
  • 世界の分子輸送培地市場の見通し、用途別、金額（10億米ドル）、2018年～2031年
  • 世界の分子輸送培地市場の見通し、サンプル別、金額（10億米ドル）、2018年～2031年
  • 世界の分子輸送培地市場の見通し、エンドユーザー別、金額（10億米ドル）、2018年～2031年
  • 世界の分子輸送培地市場の見通し、地域別、金額（10億米ドル）、2018年～2031年

第4章 北米の分子輸送培地市場の見通し、2018年～2031年

第5章 欧州の分子輸送培地市場の見通し、2018年～2031年

第6章 アジア太平洋の分子輸送培地市場の見通し、2018年～2031年

第7章 ラテンアメリカの分子輸送培地市場の見通し、2018年～2031年

第8章 中東・アフリカの分子輸送培地市場の見通し、2018年～2031年

第9章 競合情勢

  • サンプル別と用途別のヒートマップ
  • メーカーと用途別のヒートマップ
  • 企業の市場シェア分析、2023年
  • 競争力ダッシュボード
  • 企業プロファイル
    • Thermo Fisher Scientific Inc.
    • Becton, Dickinson, and Company
    • Cardinal Health
    • Quidel Corporation
    • Medical Wire & Equipment
    • COPAN Diagnostics Inc.
    • Titan Biotech Ltd.
    • Alpha Teknova, Inc.
    • Bio-Genex Laboratories Inc.
    • EKF Diagnostics

第10章 付録

目次

The global molecular transport medium market, which recorded revenues of US$ 1.6 billion in 2021, experienced a temporary dip but is now poised for steady growth. Projections indicate the market reaching US$ 1.2 billion by 2031.

Fueling Growth for Molecular Transport Medium Manufacturers

Innovative Technology - Revolutionizing Viral Transport Mediums

Technological advancements have led to a shift from traditional transport mediums to innovative molecular transport mediums, offering enhanced safety and convenience. These new products reduce exposure risks with non-hazardous and leak-proof formulations for transport, storage, and processing.

Preserving sample stability during transport and storage is another critical driver, as rapid storage is vital to prevent degradation or cell death after sample collection. Molecular transport mediums play a crucial role in maintaining sample stability during storage and transportation for approximately 48 hours, avoiding the need for freezing and thawing.

Challenges to Market Expansion

Presence of Alternative Technologies

Alternative solutions for stabilizing specimens, particularly for virus, bacteria, and fungus detection, pose a challenge to the molecular transport medium market. These solutions often use saline or buffered salt solutions to maintain a neutral pH. Researchers are exploring plant-based protein supplements to enhance virus stability.

Seasonal infections and the unpredictability of disease outbreaks affect demand for molecular transport mediums. Public awareness campaigns have increased testing rates, but demand may still outstrip supply due to the sporadic nature of infections.

Shelf-life limitations also hinder market growth, as molecular transport mediums have a short storage duration.

Country-wise Insights

U.S. Market: A Lucrative Opportunity

High awareness of disease prevention benefits, the presence of key players, and increased healthcare expenditure drive the demand for molecular transport mediums in the U.S.

Germany Market: Riding the Wave of Innovation

The launch of novel viral transport mediums, such as Thermo Fisher Scientific Inc.'s InhibiSURE, has boosted sales in European countries, including Germany, by ensuring rapid inactivation of the COVID-19 virus during collection and transport.

China Market: Government Investment

Major government investments have prompted manufacturers to increase production capacity to meet surging demand for comprehensive testing of symptomatic and asymptomatic patients, driven by COVID-19 and other infectious diseases.

India Market: Focus on Genetic Research

India's focus on genetic research and innovative product development for biological sample storage and transport, exemplified by Azooka Labs' mWRAPR, has fueled market growth. mWRAPR, India's first local biological storage and transport medium, has garnered support from institutions like Honeywell and Citigroup.

Competitive Landscape

Leading market players are expanding their production capacities to meet high demand during peak periods and offering competitive pricing. They are also developing advanced products to attract more end-users and increase market share.

Key Companies Profiled

  • Thermo Fisher Scientific Inc.
  • Becton, Dickinson, and Company
  • Cardinal Health
  • Quidel Corporation
  • Medical Wire & Equipment
  • COPAN Diagnostics Inc.
  • Titan Biotech Ltd.
  • Alpha Teknova, Inc. (formerly named Teknova)
  • Bio-Genex Laboratories Inc.
  • EKF Diagnostics
  • Trinity Biotech
  • Alpha-Tec Systems, Inc.
  • Charm Sciences, Inc.
  • Azer Scientific
  • bioBoaVista
  • AccuGene
  • KSL Diagnostics
  • Puritan Medical Products
  • Amazing Biotech (Shanghai) Co., Ltd.

Key Segments Covered in Molecular Transport Medium Industry Research

Molecular Transport Medium Market by Product Type:

  • Active Transport Medium
  • Inactivated Transport Medium

Molecular Transport Medium Market by Application:

  • Virus
    • COVID-19
    • Middle East Respiratory Syndrome (MERS)
    • Influenza
    • Human Immunodeficiency Virus (HIV)
    • Rhinovirus
    • Adenovirus
    • Respiratory Syncytial Virus (RSV)
  • Bacteria
    • Staphylococcus Pneumonia
    • Haemophilus Influenza
    • Anthrax
    • Others
  • Atypical Bacteria
    • Mycoplasma
    • Q-Fever
    • Others
  • Mycobacterial and Fungal Infection

Molecular Transport Medium Market by Sample:

  • Nasal Washes and Swabs
  • Sputum
  • Saliva
  • Faecal & Stool
  • Urine
  • Blood
  • Tissues
  • Others

Molecular Transport Medium Market by End User:

  • Diagnostic Laboratories
  • Microbiology Laboratories
  • Hospitals & Clinics
  • Others

Molecular Transport Medium Market by Region:

  • North America Molecular Transport Medium Market
  • Latin America Molecular Transport Medium Market
  • Europe Molecular Transport Medium Market
  • South Asia Molecular Transport Medium Market
  • East Asia Molecular Transport Medium Market
  • Oceania Molecular Transport Medium Market
  • The Middle East & Africa Molecular Transport Medium Market

Table of Contents

1. Executive Summary

  • 1.1. Global Molecular Transport Medium Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume, 2023
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Global Molecular Transport Medium Market Outlook, 2018 - 2031

  • 3.1. Global Molecular Transport Medium Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 3.1.1. Key Highlights
      • 3.1.1.1. Active Transport Medium
      • 3.1.1.2. Inactivated Transport Medium
  • 3.2. Global Molecular Transport Medium Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 3.2.1. Key Highlights
      • 3.2.1.1. Virus
        • 3.2.1.1.1. COVID-19
        • 3.2.1.1.2. Middle East Respiratory Syndrome (MERS)
        • 3.2.1.1.3. Influenza
        • 3.2.1.1.4. Human Immunodeficiency Virus (HIV)
        • 3.2.1.1.5. Rhinovirus
        • 3.2.1.1.6. Adenovirus
        • 3.2.1.1.7. Respiratory Syncytial Virus (RSV)
      • 3.2.1.2. Bacteria
        • 3.2.1.2.1. Staphylococcus Pneumonia
        • 3.2.1.2.2. Haemophilus Influenza
        • 3.2.1.2.3. Anthrax
        • 3.2.1.2.4. Others
      • 3.2.1.3. Atypical Bacteria
        • 3.2.1.3.1. Mycoplasma
        • 3.2.1.3.2. Q-Fever
        • 3.2.1.3.3. Others
      • 3.2.1.4. Mycobacterial and Fungal Infection
  • 3.3. Global Molecular Transport Medium Market Outlook, by Sample, Value (US$ Bn), 2018 - 2031
    • 3.3.1. Key Highlights
      • 3.3.1.1. Nasal Washes and Swabs
      • 3.3.1.2. Sputum
      • 3.3.1.3. Saliva
      • 3.3.1.4. Faecal & Stool
      • 3.3.1.5. Urine
      • 3.3.1.6. Blood
      • 3.3.1.7. Tissues
      • 3.3.1.8. Others
  • 3.4. Global Molecular Transport Medium Market Outlook, by By End User, Value (US$ Bn), 2018 - 2031
    • 3.4.1. Key Highlights
      • 3.4.1.1. Diagnostic Laboratories
      • 3.4.1.2. Microbiology Laboratories
      • 3.4.1.3. Hospitals & Clinics
      • 3.4.1.4. Others
  • 3.5. Global Molecular Transport Medium Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
    • 3.5.1. Key Highlights
      • 3.5.1.1. North America
      • 3.5.1.2. Europe
      • 3.5.1.3. Asia Pacific
      • 3.5.1.4. Latin America
      • 3.5.1.5. Middle East & Africa

4. North America Molecular Transport Medium Market Outlook, 2018 - 2031

  • 4.1. North America Molecular Transport Medium Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 4.1.1. Key Highlights
      • 4.1.1.1. Active Transport Medium
      • 4.1.1.2. Inactivated Transport Medium
  • 4.2. North America Molecular Transport Medium Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 4.2.1. Key Highlights
      • 4.2.1.1. Virus
        • 4.2.1.1.1. COVID-19
        • 4.2.1.1.2. Middle East Respiratory Syndrome (MERS)
        • 4.2.1.1.3. Influenza
        • 4.2.1.1.4. Human Immunodeficiency Virus (HIV)
        • 4.2.1.1.5. Rhinovirus
        • 4.2.1.1.6. Adenovirus
        • 4.2.1.1.7. Respiratory Syncytial Virus (RSV)
      • 4.2.1.2. Bacteria
        • 4.2.1.2.1. Staphylococcus Pneumonia
        • 4.2.1.2.2. Haemophilus Influenza
        • 4.2.1.2.3. Anthrax
        • 4.2.1.2.4. Others
      • 4.2.1.3. Atypical Bacteria
        • 4.2.1.3.1. Mycoplasma
        • 4.2.1.3.2. Q-Fever
        • 4.2.1.3.3. Others
      • 4.2.1.4. Mycobacterial and Fungal Infection
  • 4.3. North America Molecular Transport Medium Market Outlook, by Sample, Value (US$ Bn), 2018 - 2031
    • 4.3.1. Key Highlights
      • 4.3.1.1. Nasal Washes and Swabs
      • 4.3.1.2. Sputum
      • 4.3.1.3. Saliva
      • 4.3.1.4. Faecal & Stool
      • 4.3.1.5. Urine
      • 4.3.1.6. Blood
      • 4.3.1.7. Tissues
      • 4.3.1.8. Others
  • 4.4. North America Molecular Transport Medium Market Outlook, by By End User, Value (US$ Bn), 2018 - 2031
    • 4.4.1. Key Highlights
      • 4.4.1.1. Diagnostic Laboratories
      • 4.4.1.2. Microbiology Laboratories
      • 4.4.1.3. Hospitals & Clinics
      • 4.4.1.4. Others
  • 4.5. North America Molecular Transport Medium Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 4.5.1. Key Highlights
      • 4.5.1.1. U.S. Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 4.5.1.2. U.S. Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 4.5.1.3. U.S. Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 4.5.1.4. U.S. Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 4.5.1.5. Canada Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 4.5.1.6. Canada Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 4.5.1.7. Canada Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 4.5.1.8. Canada Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
    • 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Molecular Transport Medium Market Outlook, 2018 - 2031

  • 5.1. Europe Molecular Transport Medium Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 5.1.1. Key Highlights
      • 5.1.1.1. Active Transport Medium
      • 5.1.1.2. Inactivated Transport Medium
  • 5.2. Europe Molecular Transport Medium Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 5.2.1. Key Highlights
      • 5.2.1.1. Virus
        • 5.2.1.1.1. COVID-19
        • 5.2.1.1.2. Middle East Respiratory Syndrome (MERS)
        • 5.2.1.1.3. Influenza
        • 5.2.1.1.4. Human Immunodeficiency Virus (HIV)
        • 5.2.1.1.5. Rhinovirus
        • 5.2.1.1.6. Adenovirus
        • 5.2.1.1.7. Respiratory Syncytial Virus (RSV)
      • 5.2.1.2. Bacteria
        • 5.2.1.2.1. Staphylococcus Pneumonia
        • 5.2.1.2.2. Haemophilus Influenza
        • 5.2.1.2.3. Anthrax
        • 5.2.1.2.4. Others
      • 5.2.1.3. Atypical Bacteria
        • 5.2.1.3.1. Mycoplasma
        • 5.2.1.3.2. Q-Fever
        • 5.2.1.3.3. Others
      • 5.2.1.4. Mycobacterial and Fungal Infection
  • 5.3. Europe Molecular Transport Medium Market Outlook, by Sample, Value (US$ Bn), 2018 - 2031
    • 5.3.1. Key Highlights
      • 5.3.1.1. Nasal Washes and Swabs
      • 5.3.1.2. Sputum
      • 5.3.1.3. Saliva
      • 5.3.1.4. Faecal & Stool
      • 5.3.1.5. Urine
      • 5.3.1.6. Blood
      • 5.3.1.7. Tissues
      • 5.3.1.8. Others
  • 5.4. Europe Molecular Transport Medium Market Outlook, by By End User, Value (US$ Bn), 2018 - 2031
    • 5.4.1. Key Highlights
      • 5.4.1.1. Diagnostic Laboratories
      • 5.4.1.2. Microbiology Laboratories
      • 5.4.1.3. Hospitals & Clinics
      • 5.4.1.4. Others
  • 5.5. Europe Molecular Transport Medium Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 5.5.1. Key Highlights
      • 5.5.1.1. Germany Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.2. Germany Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.3. Germany Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 5.5.1.4. Germany Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.5. U.K. Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.6. U.K. Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.7. U.K. Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 5.5.1.8. U.K. Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.9. France Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.10. France Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.11. France Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 5.5.1.12. France Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.13. Italy Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.14. Italy Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.15. Italy Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 5.5.1.16. Italy Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.17. Turkey Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.18. Turkey Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.19. Turkey Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 5.5.1.20. Turkey Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.21. Russia Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.22. Russia Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.23. Russia Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 5.5.1.24. Russia Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 5.5.1.25. Rest of Europe Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 5.5.1.26. Rest of Europe Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 5.5.1.27. Rest of Europe Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 5.5.1.28. Rest of Europe Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
    • 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Molecular Transport Medium Market Outlook, 2018 - 2031

  • 6.1. Asia Pacific Molecular Transport Medium Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 6.1.1. Key Highlights
      • 6.1.1.1. Active Transport Medium
      • 6.1.1.2. Inactivated Transport Medium
  • 6.2. Asia Pacific Molecular Transport Medium Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 6.2.1. Key Highlights
      • 6.2.1.1. Virus
        • 6.2.1.1.1. COVID-19
        • 6.2.1.1.2. Middle East Respiratory Syndrome (MERS)
        • 6.2.1.1.3. Influenza
        • 6.2.1.1.4. Human Immunodeficiency Virus (HIV)
        • 6.2.1.1.5. Rhinovirus
        • 6.2.1.1.6. Adenovirus
        • 6.2.1.1.7. Respiratory Syncytial Virus (RSV)
      • 6.2.1.2. Bacteria
        • 6.2.1.2.1. Staphylococcus Pneumonia
        • 6.2.1.2.2. Haemophilus Influenza
        • 6.2.1.2.3. Anthrax
        • 6.2.1.2.4. Others
      • 6.2.1.3. Atypical Bacteria
        • 6.2.1.3.1. Mycoplasma
        • 6.2.1.3.2. Q-Fever
        • 6.2.1.3.3. Others
      • 6.2.1.4. Mycobacterial and Fungal Infection
  • 6.3. Asia Pacific Molecular Transport Medium Market Outlook, by Sample, Value (US$ Bn), 2018 - 2031
    • 6.3.1. Key Highlights
      • 6.3.1.1. Nasal Washes and Swabs
      • 6.3.1.2. Sputum
      • 6.3.1.3. Saliva
      • 6.3.1.4. Faecal & Stool
      • 6.3.1.5. Urine
      • 6.3.1.6. Blood
      • 6.3.1.7. Tissues
      • 6.3.1.8. Others
  • 6.4. Asia Pacific Molecular Transport Medium Market Outlook, by By End User, Value (US$ Bn), 2018 - 2031
    • 6.4.1. Key Highlights
      • 6.4.1.1. Diagnostic Laboratories
      • 6.4.1.2. Microbiology Laboratories
      • 6.4.1.3. Hospitals & Clinics
      • 6.4.1.4. Others
  • 6.5. Asia Pacific Molecular Transport Medium Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 6.5.1. Key Highlights
      • 6.5.1.1. China Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.2. China Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.3. China Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 6.5.1.4. China Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.5. Japan Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.6. Japan Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.7. Japan Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 6.5.1.8. Japan Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.9. South Korea Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.10. South Korea Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.11. South Korea Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 6.5.1.12. South Korea Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.13. India Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.14. India Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.15. India Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 6.5.1.16. India Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.17. Southeast Asia Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.18. Southeast Asia Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.19. Southeast Asia Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 6.5.1.20. Southeast Asia Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 6.5.1.21. Rest of Asia Pacific Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 6.5.1.22. Rest of Asia Pacific Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 6.5.1.23. Rest of Asia Pacific Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 6.5.1.24. Rest of Asia Pacific Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
    • 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Molecular Transport Medium Market Outlook, 2018 - 2031

  • 7.1. Latin America Molecular Transport Medium Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 7.1.1. Key Highlights
      • 7.1.1.1. Active Transport Medium
      • 7.1.1.2. Inactivated Transport Medium
  • 7.2. Latin America Molecular Transport Medium Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
      • 7.2.1.1. Virus
        • 7.2.1.1.1. COVID-19
        • 7.2.1.1.2. Middle East Respiratory Syndrome (MERS)
        • 7.2.1.1.3. Influenza
        • 7.2.1.1.4. Human Immunodeficiency Virus (HIV)
        • 7.2.1.1.5. Rhinovirus
        • 7.2.1.1.6. Adenovirus
        • 7.2.1.1.7. Respiratory Syncytial Virus (RSV)
      • 7.2.1.2. Bacteria
        • 7.2.1.2.1. Staphylococcus Pneumonia
        • 7.2.1.2.2. Haemophilus Influenza
        • 7.2.1.2.3. Anthrax
        • 7.2.1.2.4. Others
      • 7.2.1.3. Atypical Bacteria
        • 7.2.1.3.1. Mycoplasma
        • 7.2.1.3.2. Q-Fever
        • 7.2.1.3.3. Others
      • 7.2.1.4. Mycobacterial and Fungal Infection
  • 7.3. Latin America Molecular Transport Medium Market Outlook, by Sample, Value (US$ Bn), 2018 - 2031
    • 7.3.1. Key Highlights
      • 7.3.1.1. Nasal Washes and Swabs
      • 7.3.1.2. Sputum
      • 7.3.1.3. Saliva
      • 7.3.1.4. Faecal & Stool
      • 7.3.1.5. Urine
      • 7.3.1.6. Blood
      • 7.3.1.7. Tissues
      • 7.3.1.8. Others
  • 7.4. Latin America Molecular Transport Medium Market Outlook, by By End User, Value (US$ Bn), 2018 - 2031
    • 7.4.1. Key Highlights
      • 7.4.1.1. Diagnostic Laboratories
      • 7.4.1.2. Microbiology Laboratories
      • 7.4.1.3. Hospitals & Clinics
      • 7.4.1.4. Others
  • 7.5. Latin America Molecular Transport Medium Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 7.5.1. Key Highlights
      • 7.5.1.1. Brazil Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.5.1.2. Brazil Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 7.5.1.3. Brazil Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 7.5.1.4. Brazil Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 7.5.1.5. Mexico Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.5.1.6. Mexico Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 7.5.1.7. Mexico Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 7.5.1.8. Mexico Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 7.5.1.9. Argentina Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.5.1.10. Argentina Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 7.5.1.11. Argentina Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 7.5.1.12. Argentina Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 7.5.1.13. Rest of Latin America Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 7.5.1.14. Rest of Latin America Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 7.5.1.15. Rest of Latin America Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 7.5.1.16. Rest of Latin America Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
    • 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Molecular Transport Medium Market Outlook, 2018 - 2031

  • 8.1. Middle East & Africa Molecular Transport Medium Market Outlook, by Product Type, Value (US$ Bn), 2018 - 2031
    • 8.1.1. Key Highlights
      • 8.1.1.1. Active Transport Medium
      • 8.1.1.2. Inactivated Transport Medium
  • 8.2. Middle East & Africa Molecular Transport Medium Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
    • 8.2.1. Key Highlights
      • 8.2.1.1. v
  • 8.3. Middle East & Africa Molecular Transport Medium Market Outlook, by Sample, Value (US$ Bn), 2018 - 2031
    • 8.3.1. Key Highlights
      • 8.3.1.1. Nasal Washes and Swabs
      • 8.3.1.2. Sputum
      • 8.3.1.3. Saliva
      • 8.3.1.4. Faecal & Stool
      • 8.3.1.5. Urine
      • 8.3.1.6. Blood
      • 8.3.1.7. Tissues
      • 8.3.1.8. Others
  • 8.4. Middle East & Africa Molecular Transport Medium Market Outlook, by By End User, Value (US$ Bn), 2018 - 2031
    • 8.4.1. Key Highlights
      • 8.4.1.1. Diagnostic Laboratories
      • 8.4.1.2. Microbiology Laboratories
      • 8.4.1.3. Hospitals & Clinics
      • 8.4.1.4. Others
  • 8.5. Middle East & Africa Molecular Transport Medium Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
    • 8.5.1. Key Highlights
      • 8.5.1.1. GCC Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.2. GCC Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 8.5.1.3. GCC Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 8.5.1.4. GCC Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.5. South Africa Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.6. South Africa Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 8.5.1.7. South Africa Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 8.5.1.8. South Africa Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.9. Egypt Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.10. Egypt Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 8.5.1.11. Egypt Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 8.5.1.12. Egypt Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.13. Nigeria Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.14. Nigeria Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 8.5.1.15. Nigeria Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 8.5.1.16. Nigeria Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
      • 8.5.1.17. Rest of Middle East & Africa Molecular Transport Medium Market by Product Type, Value (US$ Bn), 2018 - 2031
      • 8.5.1.18. Rest of Middle East & Africa Molecular Transport Medium Market By Application, Value (US$ Bn), 2018 - 2031
      • 8.5.1.19. Rest of Middle East & Africa Molecular Transport Medium Market By Sample, Value (US$ Bn), 2018 - 2031
      • 8.5.1.20. Rest of Middle East & Africa Molecular Transport Medium Market By End User, Value (US$ Bn), 2018 - 2031
    • 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. By Sample vs By Application Heatmap
  • 9.2. Manufacturer vs By Application Heatmap
  • 9.3. Company Market Share Analysis, 2023
  • 9.4. Competitive Dashboard
  • 9.5. Company Profiles
    • 9.5.1. Thermo Fisher Scientific Inc.
      • 9.5.1.1. Company Overview
      • 9.5.1.2. Product Portfolio
      • 9.5.1.3. Financial Overview
      • 9.5.1.4. Business Strategies and Development
    • 9.5.2. Becton, Dickinson, and Company
      • 9.5.2.1. Company Overview
      • 9.5.2.2. Product Portfolio
      • 9.5.2.3. Financial Overview
      • 9.5.2.4. Business Strategies and Development
    • 9.5.3. Cardinal Health
      • 9.5.3.1. Company Overview
      • 9.5.3.2. Product Portfolio
      • 9.5.3.3. Financial Overview
      • 9.5.3.4. Business Strategies and Development
    • 9.5.4. Quidel Corporation
      • 9.5.4.1. Company Overview
      • 9.5.4.2. Product Portfolio
      • 9.5.4.3. Financial Overview
      • 9.5.4.4. Business Strategies and Development
    • 9.5.5. Medical Wire & Equipment
      • 9.5.5.1. Company Overview
      • 9.5.5.2. Product Portfolio
      • 9.5.5.3. Financial Overview
      • 9.5.5.4. Business Strategies and Development
    • 9.5.6. COPAN Diagnostics Inc.
      • 9.5.6.1. Company Overview
      • 9.5.6.2. Product Portfolio
      • 9.5.6.3. Financial Overview
      • 9.5.6.4. Business Strategies and Development
    • 9.5.7. Titan Biotech Ltd.
      • 9.5.7.1. Company Overview
      • 9.5.7.2. Product Portfolio
      • 9.5.7.3. Financial Overview
      • 9.5.7.4. Business Strategies and Development
    • 9.5.8. Alpha Teknova, Inc. [former named Teknova]
      • 9.5.8.1. Company Overview
      • 9.5.8.2. Product Portfolio
      • 9.5.8.3. Financial Overview
      • 9.5.8.4. Business Strategies and Development
    • 9.5.9. Bio-Genex Laboratories Inc.
      • 9.5.9.1. Company Overview
      • 9.5.9.2. Product Portfolio
      • 9.5.9.3. Financial Overview
      • 9.5.9.4. Business Strategies and Development
    • 9.5.10. EKF Diagnostics
      • 9.5.10.1. Company Overview
      • 9.5.10.2. Product Portfolio
      • 9.5.10.3. Financial Overview
      • 9.5.10.4. Business Strategies and Development

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations